ArticleJournal of thoracic disease2019

The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker.

Kazutoshi Hamanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.